Teva Net Debt vs Deferred Long Term Liab Analysis

TEVA Stock  USD 22.21  0.12  0.54%   
Teva Pharma financial indicator trend analysis is much more than just breaking down Teva Pharma Industries prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Teva Pharma Industries is a good investment. Please check the relationship between Teva Pharma Net Debt and its Deferred Long Term Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Net Debt vs Deferred Long Term Liab

Net Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Teva Pharma Industries Net Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Teva Pharma's Net Debt and Deferred Long Term Liab is 0.58. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Teva Pharma Industries, assuming nothing else is changed. The correlation between historical values of Teva Pharma's Net Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Teva Pharma Industries are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Net Debt i.e., Teva Pharma's Net Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.58
Relationship DirectionPositive 
Relationship StrengthWeak

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.
Most indicators from Teva Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Teva Pharma Industries current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
At present, Teva Pharma's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 34.2 B, whereas Tax Provision is forecasted to decline to (7.3 M).
 2021 2023 2024 (projected)
Interest Expense1.1B1.0B1.1B
Depreciation And Amortization1.3B1.2B1.2B

Teva Pharma fundamental ratios Correlations

0.760.250.960.710.910.730.270.020.990.520.020.930.620.740.810.190.40.830.850.710.920.13-0.14-0.670.57
0.760.450.710.140.660.99-0.38-0.140.8-0.04-0.140.60.731.00.490.070.80.980.430.560.82-0.40.4-0.480.83
0.250.450.180.010.180.43-0.290.010.29-0.140.010.050.370.490.070.630.530.460.070.230.21-0.360.37-0.250.61
0.960.710.180.660.960.670.230.060.930.550.060.950.70.680.90.290.410.790.90.790.850.18-0.12-0.770.48
0.710.140.010.660.610.10.820.230.650.890.230.790.060.130.660.18-0.170.290.80.470.560.62-0.61-0.570.08
0.910.660.180.960.610.610.170.160.860.560.160.890.790.630.920.390.480.740.920.680.710.280.0-0.840.42
0.730.990.430.670.10.61-0.37-0.30.79-0.06-0.30.580.670.980.460.010.730.950.350.560.82-0.480.36-0.40.78
0.27-0.38-0.290.230.820.17-0.370.030.210.810.030.42-0.42-0.40.320.0-0.7-0.260.420.190.170.66-0.89-0.12-0.43
0.02-0.140.010.060.230.16-0.30.03-0.070.131.00.010.18-0.10.080.30.24-0.040.39-0.17-0.210.570.18-0.380.15
0.990.80.290.930.650.860.790.21-0.070.44-0.070.890.590.790.740.120.420.860.760.680.950.02-0.12-0.590.62
0.52-0.04-0.140.550.890.56-0.060.810.130.440.130.710.01-0.060.690.24-0.270.110.710.420.330.74-0.61-0.63-0.15
0.02-0.140.010.060.230.16-0.30.031.0-0.070.130.010.18-0.10.080.30.24-0.040.39-0.17-0.210.570.18-0.380.15
0.930.60.050.950.790.890.580.420.010.890.710.010.510.560.890.20.240.690.890.780.840.27-0.29-0.750.32
0.620.730.370.70.060.790.67-0.420.180.590.010.180.510.720.650.490.820.730.60.490.45-0.120.54-0.70.55
0.741.00.490.680.130.630.98-0.4-0.10.79-0.06-0.10.560.720.460.070.820.980.410.50.8-0.390.43-0.470.88
0.810.490.070.90.660.920.460.320.080.740.690.080.890.650.460.40.290.590.910.770.620.36-0.13-0.860.19
0.190.070.630.290.180.390.010.00.30.120.240.30.20.490.070.40.290.130.420.37-0.050.140.14-0.570.08
0.40.80.530.41-0.170.480.73-0.70.240.42-0.270.240.240.820.820.290.290.780.270.240.36-0.350.81-0.520.79
0.830.980.460.790.290.740.95-0.26-0.040.860.11-0.040.690.730.980.590.130.780.560.60.85-0.260.33-0.60.85
0.850.430.070.90.80.920.350.420.390.760.710.390.890.60.410.910.420.270.560.650.620.52-0.21-0.850.27
0.710.560.230.790.470.680.560.19-0.170.680.42-0.170.780.490.50.770.370.240.60.650.71-0.1-0.19-0.580.23
0.920.820.210.850.560.710.820.17-0.210.950.33-0.210.840.450.80.62-0.050.360.850.620.71-0.16-0.16-0.430.61
0.13-0.4-0.360.180.620.28-0.480.660.570.020.740.570.27-0.12-0.390.360.14-0.35-0.260.52-0.1-0.16-0.45-0.41-0.32
-0.140.40.37-0.12-0.610.00.36-0.890.18-0.12-0.610.18-0.290.540.43-0.130.140.810.33-0.21-0.19-0.16-0.45-0.140.45
-0.67-0.48-0.25-0.77-0.57-0.84-0.4-0.12-0.38-0.59-0.63-0.38-0.75-0.7-0.47-0.86-0.57-0.52-0.6-0.85-0.58-0.43-0.41-0.14-0.36
0.570.830.610.480.080.420.78-0.430.150.62-0.150.150.320.550.880.190.080.790.850.270.230.61-0.320.45-0.36
Click cells to compare fundamentals

Teva Pharma Account Relationship Matchups

Teva Pharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets57.5B50.6B47.7B44.0B43.5B26.4B
Short Long Term Debt Total27.3B26.4B23.5B21.6B20.2B21.2B
Other Current Liab890M8.1B7.8B7.4B8.0B8.4B
Total Current Liabilities13.7B13.2B11.0B11.5B12.2B6.5B
Total Stockholder Equity14.0B10.0B10.3B7.9B7.5B9.9B
Property Plant And Equipment Net7.0B6.9B6.5B6.2B6.1B3.2B
Net Debt25.4B24.2B21.3B18.8B16.9B17.8B
Retained Earnings(7.0B)(10.9B)(10.5B)(12.9B)(13.5B)(12.9B)
Cash2.0B2.2B2.2B2.8B3.2B3.4B
Non Current Assets Total44.0B37.6B35.1B32.0B31.0B18.7B
Non Currrent Assets Other591M538M515M441M463M594.6M
Cash And Short Term Investments2.0B2.2B2.2B2.8B3.2B3.4B
Net Receivables5.7B4.6B4.5B3.7B3.4B3.0B
Common Stock Shares Outstanding1.1B1.1B1.1B1.1B1.1B777.0M
Liabilities And Stockholders Equity57.5B50.6B47.7B44.0B43.5B26.4B
Non Current Liabilities Total28.7B26.4B25.4B23.8B23.1B24.3B
Inventory4.4B4.4B3.8B3.8B4.0B2.4B
Other Current Assets434M1.8B2.1B1.7B1.8B1.1B
Other Stockholder Equity23.2B23.3B23.4B23.6B23.7B24.9B
Total Liab42.4B39.6B36.4B35.3B35.4B37.1B
Total Current Assets13.5B13.0B12.6B12.1B12.5B7.7B
Short Term Debt2.3B3.3B1.5B2.2B1.7B1.3B
Intangible Assets11.2B8.9B7.5B6.3B5.4B4.7B
Accounts Payable1.7B1.8B1.7B1.9B2.6B2.1B
Accumulated Other Comprehensive Income(2.3B)(2.4B)(2.7B)(2.8B)(2.7B)(2.6B)
Other Liab3.7B3.2B3.4B4.4B5.1B5.3B
Other Assets2.1B1.1B1M(1M)1.9B950K
Long Term Debt24.6B22.7B21.6B19.1B18.2B12.5B
Property Plant Equipment6.4B6.3B6.0B6.2B7.1B4.8B
Current Deferred Revenue8.7B7.3B7.0B1.5B4.9B3.1B
Good Will24.8B20.6B20.0B17.6B17.2B17.7B
Property Plant And Equipment Gross6.4B6.9B6.5B6.2B11.8B12.4B
Short Long Term Debt2.3B3.2B1.4B2.1B1.7B2.6B
Net Tangible Assets(22.1B)(19.5B)(17.2B)(16.0B)(14.4B)(15.1B)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.4
Earnings Share
(0.85)
Revenue Per Share
14.879
Quarterly Revenue Growth
0.125
Return On Assets
0.0556
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.